CFS Clinical Trials

12 recruitingLast updated: May 13, 2026

There are 12 actively recruiting cfs clinical trials across 5 countries. Studies span Phase 2, Not Applicable. Top locations include Munich, Bavaria, Germany, Berlin, State of Berlin, Germany, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


CFS Trials at a Glance

12 actively recruiting trials for cfs are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Munich, Berlin, and Boston. Lead sponsors running cfs studies include Technical University of Munich, Charite University, Berlin, Germany, and Brigham and Women's Hospital.

Browse cfs trials by phase

Treatments under study

About CFS Clinical Trials

Looking for clinical trials for CFS? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new CFS trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about CFS clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Patient-Centered Assessment of Symptoms and Outcomes

Myalgic Encephalomyelitis/Chronic Fatigue SyndromeCancerFatigue+5 more
National Center for Complementary and Integrative Health (NCCIH)692 enrolled1 locationNCT03952624
Recruiting

Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)ME/CFS Following COVID-19
Charite University, Berlin, Germany50 enrolled1 locationNCT07529197
Recruiting
Not Applicable

Effect of Physical Exercise and Neuromodulation on Pain, Sleep and Fatigue in Patients With Fibromyalgia

FibromyalgiaChronic Fatigue Syndrome (CFS)
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland75 enrolled1 locationNCT07242573
Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Traumatic Brain InjuryEhlers-Danlos SyndromePost-Acute COVID-19 Syndrome+41 more
Brain Inflammation Collaborative10,000 enrolled1 locationNCT04806620
Recruiting
Not Applicable

OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause (ACCESS)

ME/CFS
Hannover Medical School100 enrolled1 locationNCT07352254
Recruiting
Phase 2

LIFT: Life Improvement Trial

ME/CFSLong COVIDPASC
Brigham and Women's Hospital160 enrolled1 locationNCT06366724
Recruiting
Phase 2

Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
National Center of Neurology and Psychiatry, Japan30 enrolled1 locationNCT06952413
Recruiting
Phase 2

The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

ME/CFSIBS - Irritable Bowel Syndrome
Nova Southeastern University100 enrolled1 locationNCT06211062
Recruiting

Hyperbaric High Pressure Oxygen Therapy in Post-COVID Syndrome and ME/CFS

Post-COVID ME/CFS
Charite University, Berlin, Germany60 enrolled1 locationNCT06118138
Recruiting

Multi-Center Registry for ME/CFS

ME/CFSCFS/MEME/CFS Following EBV-associated Infectious Mononucleosis+1 more
Technical University of Munich650 enrolled1 locationNCT05778006
Recruiting

FUNCAP-27 (Functional Capacity), A Repeat Measure Study (FARMS), A survey to establish the utility of the FUNCAP-27 for serial measurements in Myalgic Encephalomyelitis, Chronic Fatigue Syndrome (ME/CFS) and Long Covid

ME/CFS (Myalgic Encephalomyelitis / Chronic Fatigue Syndrome)
The University of Melbourne1,000 enrolled1 locationACTRN12624001479594
Recruiting

Munich ME/CFS Cohort Study

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)
Technical University of Munich200 enrolled1 locationNCT06005246